Dr. James Kenneth Byrd, MD

Dr. Byrd practices at Wellstar MCG Health Medical Center in Augusta, Georgia, part of Wellstar Health System.

Dr. Byrd's NPI, 1720285166, was assigned on June 29, 2007. Dr. Byrd graduated from Medical University of South Carolina (MUSC) in 2007. Dr. Byrd holds Georgia license 072220.

Dr. Byrd's primary practice is Wellstar MCG Health Medical Center, at 1120 15th Street, Augusta, GA 30912 in Richmond County. The practice phone is (706) 721-6569.

Dr. Byrd's primary practice is Wellstar MCG Health Medical Center in Augusta, Georgia, part of Wellstar Health System. The medical group on file is Wellstar Medical Group. Dmand AI also links Dr. Byrd to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Byrd practices. Vendor and product names are available with a free account.

Otolaryngology is Dr. Byrd's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Byrd is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Byrd's licenses on file in 3 states: Georgia, South Carolina and Pennsylvania.

Dmand AI lists endoscopic sinus surgery among the conditions Dr. Byrd treats.

CMS data shows 258 Medicare services from Dr. Byrd across 8 procedure codes in 2024, for 155 Medicare patients. Medicare paid $26,106 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 155 Medicare patients who saw Dr. Byrd in 2024. The largest group is 65 to 74, with 80 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.50, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Byrd's median patient age at 71, with 35% women.

In 2024, Dr. Byrd wrote 31 Medicare Part D claims for 19 patients. 100% of them were for generic drugs. CMS names the drug for 15 of them, across 1 drug with 11 or more claims each, at $262 in total drug cost. In 2023, CMS named 20 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Byrd for performance year 2024, reported through an alternative payment model (APM). Dr. Byrd accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 49 papers to Dr. Byrd, published from 2014 to 2025. 2019 was the busiest year, with 11. The most frequent topics are Head and Neck Neoplasms, Carcinoma, Squamous Cell and Robotic Surgical Procedures. Dr. Byrd has published most often in Laryngoscope. Dr. Byrd's most frequent co-authors are William Greer Albergotti, MD, Michael William Groves, MD and Daniel Davis Sharbel, MD.

CMS Open Payments shows 35 general payments to Dr. Byrd from 12 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 51% of the total. Intuitive Surgical, Inc. paid the most, $882.

Dmand AI lists 1 award for Dr. Byrd.

Dr. Byrd graduated from Medical University of South Carolina (MUSC) in 2007. Dr. Byrd is a member of NHS.

Dr. Byrd is in network with 18 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.